Bernstein Initiates Coverage On BioNTech with Market Perform Rating, Announces Price Target of $96

Benzinga Newsdesk www.benzinga.com Positive 58.7%

Neg 0% Neu 0% Pos 58.7%

Bernstein analyst Jeffrey Walch initiates coverage on BioNTech (NASDAQ:BNTX) with a Market Perform rating and announces Price Target of $96.